| SpectraBase Spectrum ID |
JFaVABghNJY |
| Name |
N,N-Dibutyl-2-(2,3-dihydroindol-3-yl)ethanamine |
| Classification |
Designer drug side product |
| Copyright |
Copyright © 2024-2025 DigiLab GmbH and Wiley-VCH GmbH. All Rights Reserved. |
| Exact Mass |
274.240898974 u |
| Formula |
C18H30N2 |
| InChI |
InChI=1S/C18H30N2/c1-3-5-12-20(13-6-4-2)14-11-16-15-19-18-10-8-7-9-17(16)18/h7-10,16,19H,3-6,11-15H2,1-2H3 |
| InChIKey |
FBLDXCTVGYKFQJ-UHFFFAOYSA-N |
| Ionization Type |
Electron Ionization (EI) |
| Molecular Weight |
274.452 g/mol |
| Nominal Mass |
274 u |
| Quality |
899 |
| Retention Index |
2196 |
| SMILES |
C=12C(NCC2CCN(CCCC)CCCC)=CC=CC1 |
| SPLASH |
splash10-0f79-9700000000-7880bebbb17fb2208925 |
| Source of Spectrum |
DigiLab GmbH (C) 2024 |
| Synonyms |
N-butyl-N-(2-(2,3-dihydro-1H-indol-3-yl)ethyl)butan-1-amine |
| Technique |
GC/MS |
| Wiley ID |
DD2024_016026 |
